119:(PPI). Public involvement involves a working partnership between patients, caregivers, people with lived experience, and researchers to shape and influence what is researcher and how. PPI can improve the quality of research and make it more relevant and accessible. People with current or past experience of illness can provide a different perspective than professionals and compliment their knowledge. Through their personal knowledge they can identify research topics that are relevant and important to those living with an illness or using a service. They can also help to make the research more grounded in the needs of the specific communities they are part of. Public contributors can also ensure that the research is presented in
178:), or when an approved or cleared test article is used in a way that may significantly increase the risks (or decreases the acceptability of the risks), the data obtained from the preclinical studies or other supporting evidence, or case studies of off label use are submitted to the FDA in support of an
73:
Clinical research is different from clinical practice: in clinical practice, established treatments are used to improve the condition of a person, while in clinical research, evidence is collected under rigorous study conditions on groups of people to determine the efficacy and safety of a treatment.
90:
on human participants. Clinical research can cover any medical method or product from its inception in the lab to its introduction to the consumer market and beyond. Once the promising candidate or the molecule is identified in the lab, it is subjected to pre-clinical studies or animal studies where
152:
Phase I includes 20 to 100 healthy volunteers or individuals with the disease or condition. This study typically lasts several months and its purpose is to prove safety and an effective dosage. Phase II includes a larger number of individual participants in the range of 100–300, and Phase III
102:
The clinical research ecosystem involves a complex network of sites, pharmaceutical companies and academic research institutions. Clinical research is often conducted at academic medical centers and affiliated research study sites. These centers and sites provide the prestige of the academic
209:
acts in a similar fashion for studies conducted in their region. These human studies are conducted in four phases in research subjects that give consent to participate in the clinical trials.
193:
or
Research Ethics Board and possibly other institutional committee reviews, Privacy Board, Conflict of Interest Committee, Radiation Safety Committee or Radioactive Drug Research Committee.
82:
The term "clinical research" refers to the entire process of studying and writing about a drug, a medical device or a form of treatment, which includes conducting interventional studies (
1094:
115:
Besides being participants in a clinical trial, members of the public can actively collaborate with researchers in designing and conducting clinical research. This is known as
563:
145:. If the drug successfully passes through Phases I, II, and III, it will be approved by the national regulatory authority for use in the general population. Phase IV is
411:
103:
institution as well as access to larger metropolitan areas, providing a larger pool of medical participants. These academic medical centers often have their internal
436:
189:
application if the device is a significant risk device or is not in some way exempt from prior submission to the FDA. In addition, clinical research may require
70:
intended for improving human health. These research procedures are designed for the prevention, treatment, diagnosis or understanding of disease symptoms.
153:
includes some 1000-3000 participants to assess efficacy and safety of the drug at different doses. Only 25-30% of drugs advance to the end of Phase III.
1087:
855:
851:
901:
859:
847:
348:
141:, clinical trials involving new drugs are commonly classified into four phases. Each phase of the drug approval process is treated as a separate
556:
1222:
1080:
1022:
938:
1133:
549:
311:
1060:
228:
186:
243:
905:
627:
116:
738:
1262:
1053:
1230:
1032:
171:
996:
968:
897:
651:
233:
218:
132:
1306:
1275:
1046:
722:
190:
104:
37:
1280:
841:
206:
1311:
1285:
1207:
779:
727:
607:
223:
179:
1240:
867:
825:
803:
773:
673:
617:
600:
238:
138:
976:
734:
523:
1158:
813:
817:
704:
695:
642:
612:
576:
1118:
1103:
783:
1128:
690:
622:
412:"Public Information Pack (PIP): How to get involved in NHS, public health and social care research"
87:
943:
893:
708:
637:
595:
476:
285:. ClinicalTrials.gov, National Library of Medicine, US National Institutes of Health. 24 May 2023
501:
1143:
1138:
1017:
981:
948:
873:
795:
393:
282:
67:
461:
Ball, Sarah; Harshfield, Amelia; Carpenter, Asha; Bertscher, Adam; Marjanovic, Sonja (2019).
437:"Briefing notes for researchers - public involvement in NHS, health and social care research"
1270:
1148:
1123:
791:
712:
666:
661:
541:
468:
383:
47:
1192:
1176:
986:
809:
764:
462:
1246:
1235:
1212:
1197:
1012:
933:
885:
678:
590:
388:
371:
202:
142:
120:
83:
59:
31:
1300:
991:
958:
953:
480:
167:
123:
that is clear to the wider society and the specific groups it is most relevant for.
833:
717:
17:
1252:
1027:
881:
754:
744:
63:
55:
1072:
829:
821:
787:
749:
656:
372:"Continuing review of ethics in clinical trials: a surveillance study in Iran"
314:. National Institute on Aging, US National Institutes of Health. 22 March 2023
464:
Patient and public involvement in research: Enabling meaningful contributions
1202:
889:
877:
397:
923:
96:
92:
51:
1171:
928:
185:
Where devices are concerned the submission to the FDA would be for an
472:
1076:
545:
175:
170:, when a test article is unapproved or not yet cleared by the
50:
that involves people and aims to determine the effectiveness (
91:
different aspects of the test article (including its safety
370:
Mohamadi, Amin; Asghari, Fariba; Rashidian, Arash (2014).
502:"The Drug Development Process; Step 3: Clinical Research"
36:"Clinical science" redirects here. For the journal, see
107:
that oversee the ethical conduct of medical research.
349:"What Are the Different Types of Clinical Research?"
1261:
1221:
1185:
1157:
1111:
1005:
967:
916:
866:
840:
802:
772:
763:
689:
636:
583:
504:. US Food and Drug Administration. 4 January 2018
376:Journal of Medical Ethics and History of Medicine
351:. US Food and Drug Administration. 4 January 2018
99:, if possible at this early stage) are studied.
441:National Institute for Health and Care Research
416:National Institute for Health and Care Research
1088:
557:
8:
526:. European Medicines Agency. 30 October 2023
343:
341:
339:
337:
335:
333:
331:
329:
1095:
1081:
1073:
769:
564:
550:
542:
27:Medical research using human test subjects
496:
494:
492:
490:
387:
856:Preventable fraction among the unexposed
852:Attributable fraction for the population
860:Preventable fraction for the population
848:Attributable fraction among the exposed
312:"What Are Clinical Trials and Studies?"
255:
1223:Guidelines for human subject research
306:
304:
302:
300:
277:
275:
273:
271:
269:
267:
265:
263:
261:
259:
7:
1023:Correlation does not imply causation
939:Animal testing on non-human primates
25:
1134:Privacy for research participants
229:Clinical trial management system
187:Investigational Device Exemption
244:Unethical human experimentation
906:Pre- and post-test probability
628:Patient and public involvement
117:patient and public involvement
111:Patient and public involvement
1:
1263:Monitoring in clinical trials
1231:List of medical ethics cases
1033:Sex as a biological variable
524:"Authorisation of medicines"
172:Food and Drug Administration
157:Clinical research by country
997:Intention-to-treat analysis
969:Analysis of clinical trials
898:Specificity and sensitivity
652:Randomized controlled trial
234:Randomized controlled trial
219:Clinical research associate
133:Phases of clinical research
105:Institutional Review Boards
1328:
1276:Institutional review board
191:Institutional Review Board
130:
38:Clinical Science (journal)
35:
29:
1281:Data monitoring committee
1041:
1006:Interpretation of results
739:Nested case–control study
207:European Medicines Agency
1286:Community advisory board
1208:Clinical research ethics
608:Academic clinical trials
224:Clinical research ethics
180:Investigational New Drug
1241:Declaration of Helsinki
826:Relative risk reduction
674:Adaptive clinical trial
618:Evidence-based medicine
601:Adaptive clinical trial
239:Evidence-based medicine
1159:Human subject research
814:Number needed to treat
818:Number needed to harm
705:Cross-sectional study
657:Scientific experiment
613:Clinical study design
283:"Learn about studies"
88:observational studies
1104:Research participant
784:Cumulative incidence
467:. RAND Corporation.
139:preclinical research
1129:Respect for persons
691:Observational study
623:Real world evidence
577:experimental design
64:diagnostic products
977:Risk–benefit ratio
944:First-in-man study
894:Case fatality rate
735:Case–control study
709:Longitudinal study
95:if applicable and
68:treatment regimens
1307:Clinical research
1294:
1293:
1167:Clinical research
1144:Return of results
1139:Right to withdraw
1070:
1069:
1018:Survivorship bias
982:Systematic review
949:Multicenter trial
912:
911:
902:Likelihood-ratios
874:Clinical endpoint
842:Population impact
796:Period prevalence
573:Clinical research
44:Clinical research
18:Clinical Research
16:(Redirected from
1319:
1271:Ethics committee
1149:Informed consent
1097:
1090:
1083:
1074:
917:Trial/test types
792:Point prevalence
770:
713:Ecological study
696:EBM II-2 to II-3
667:Open-label trial
662:Blind experiment
638:Controlled study
566:
559:
552:
543:
536:
535:
533:
531:
520:
514:
513:
511:
509:
498:
485:
484:
458:
452:
451:
449:
447:
433:
427:
426:
424:
422:
408:
402:
401:
391:
367:
361:
360:
358:
356:
345:
324:
323:
321:
319:
308:
295:
294:
292:
290:
279:
54:) and safety of
48:medical research
21:
1327:
1326:
1322:
1321:
1320:
1318:
1317:
1316:
1312:Health research
1297:
1296:
1295:
1290:
1257:
1217:
1193:Research ethics
1186:Ethical systems
1181:
1177:Social research
1153:
1107:
1101:
1071:
1066:
1037:
1001:
963:
908:
862:
836:
810:Risk difference
798:
759:
693:
685:
640:
632:
596:Trial protocols
579:
570:
540:
539:
529:
527:
522:
521:
517:
507:
505:
500:
499:
488:
460:
459:
455:
445:
443:
435:
434:
430:
420:
418:
410:
409:
405:
369:
368:
364:
354:
352:
347:
346:
327:
317:
315:
310:
309:
298:
288:
286:
281:
280:
257:
252:
215:
199:
164:
159:
135:
129:
113:
84:clinical trials
80:
46:is a branch of
41:
34:
28:
23:
22:
15:
12:
11:
5:
1325:
1323:
1315:
1314:
1309:
1299:
1298:
1292:
1291:
1289:
1288:
1283:
1278:
1273:
1267:
1265:
1259:
1258:
1256:
1255:
1250:
1247:Belmont Report
1243:
1238:
1236:Nuremberg Code
1233:
1227:
1225:
1219:
1218:
1216:
1215:
1213:Biobank ethics
1210:
1205:
1200:
1198:Medical ethics
1195:
1189:
1187:
1183:
1182:
1180:
1179:
1174:
1169:
1163:
1161:
1155:
1154:
1152:
1151:
1146:
1141:
1136:
1131:
1126:
1121:
1115:
1113:
1109:
1108:
1102:
1100:
1099:
1092:
1085:
1077:
1068:
1067:
1065:
1064:
1061:List of topics
1057:
1050:
1042:
1039:
1038:
1036:
1035:
1030:
1025:
1020:
1015:
1013:Selection bias
1009:
1007:
1003:
1002:
1000:
999:
994:
989:
984:
979:
973:
971:
965:
964:
962:
961:
956:
951:
946:
941:
936:
934:Animal testing
931:
926:
920:
918:
914:
913:
910:
909:
886:Mortality rate
872:
870:
864:
863:
846:
844:
838:
837:
808:
806:
800:
799:
778:
776:
767:
761:
760:
758:
757:
752:
747:
742:
732:
731:
730:
725:
715:
701:
699:
687:
686:
684:
683:
682:
681:
679:Platform trial
671:
670:
669:
664:
659:
648:
646:
634:
633:
631:
630:
625:
620:
615:
610:
605:
604:
603:
598:
591:Clinical trial
587:
585:
581:
580:
571:
569:
568:
561:
554:
546:
538:
537:
515:
486:
473:10.7249/rr2678
453:
428:
403:
362:
325:
296:
254:
253:
251:
248:
247:
246:
241:
236:
231:
226:
221:
214:
211:
203:European Union
198:
197:European Union
195:
182:application.
163:
160:
158:
155:
143:clinical trial
131:Main article:
128:
125:
121:plain language
112:
109:
79:
76:
32:Clinical trial
26:
24:
14:
13:
10:
9:
6:
4:
3:
2:
1324:
1313:
1310:
1308:
1305:
1304:
1302:
1287:
1284:
1282:
1279:
1277:
1274:
1272:
1269:
1268:
1266:
1264:
1260:
1254:
1251:
1249:
1248:
1244:
1242:
1239:
1237:
1234:
1232:
1229:
1228:
1226:
1224:
1220:
1214:
1211:
1209:
1206:
1204:
1201:
1199:
1196:
1194:
1191:
1190:
1188:
1184:
1178:
1175:
1173:
1170:
1168:
1165:
1164:
1162:
1160:
1156:
1150:
1147:
1145:
1142:
1140:
1137:
1135:
1132:
1130:
1127:
1125:
1122:
1120:
1117:
1116:
1114:
1110:
1105:
1098:
1093:
1091:
1086:
1084:
1079:
1078:
1075:
1063:
1062:
1058:
1056:
1055:
1051:
1049:
1048:
1044:
1043:
1040:
1034:
1031:
1029:
1026:
1024:
1021:
1019:
1016:
1014:
1011:
1010:
1008:
1004:
998:
995:
993:
992:Meta-analysis
990:
988:
985:
983:
980:
978:
975:
974:
972:
970:
966:
960:
959:Vaccine trial
957:
955:
954:Seeding trial
952:
950:
947:
945:
942:
940:
937:
935:
932:
930:
927:
925:
922:
921:
919:
915:
907:
903:
899:
895:
891:
887:
883:
879:
875:
871:
869:
865:
861:
857:
853:
849:
845:
843:
839:
835:
831:
827:
823:
819:
815:
811:
807:
805:
801:
797:
793:
789:
785:
781:
777:
775:
771:
768:
766:
762:
756:
753:
751:
748:
746:
743:
740:
736:
733:
729:
726:
724:
723:Retrospective
721:
720:
719:
716:
714:
710:
706:
703:
702:
700:
697:
692:
688:
680:
677:
676:
675:
672:
668:
665:
663:
660:
658:
655:
654:
653:
650:
649:
647:
644:
643:EBM I to II-1
639:
635:
629:
626:
624:
621:
619:
616:
614:
611:
609:
606:
602:
599:
597:
594:
593:
592:
589:
588:
586:
582:
578:
574:
567:
562:
560:
555:
553:
548:
547:
544:
525:
519:
516:
503:
497:
495:
493:
491:
487:
482:
478:
474:
470:
466:
465:
457:
454:
442:
438:
432:
429:
417:
413:
407:
404:
399:
395:
390:
385:
381:
377:
373:
366:
363:
350:
344:
342:
340:
338:
336:
334:
332:
330:
326:
313:
307:
305:
303:
301:
297:
284:
278:
276:
274:
272:
270:
268:
266:
264:
262:
260:
256:
249:
245:
242:
240:
237:
235:
232:
230:
227:
225:
222:
220:
217:
216:
212:
210:
208:
204:
196:
194:
192:
188:
183:
181:
177:
173:
169:
168:United States
162:United States
161:
156:
154:
150:
148:
147:post-approval
144:
140:
134:
126:
124:
122:
118:
110:
108:
106:
100:
98:
94:
89:
85:
77:
75:
71:
69:
65:
61:
57:
53:
49:
45:
39:
33:
19:
1245:
1166:
1059:
1052:
1045:
834:Hazard ratio
718:Cohort study
572:
528:. Retrieved
518:
506:. Retrieved
463:
456:
444:. Retrieved
440:
431:
419:. Retrieved
415:
406:
379:
375:
365:
353:. Retrieved
316:. Retrieved
287:. Retrieved
200:
184:
165:
151:
146:
136:
114:
101:
81:
72:
43:
42:
1253:Common Rule
1119:Beneficence
1028:Null result
987:Replication
882:Infectivity
804:Association
755:Case report
745:Case series
728:Prospective
78:Description
56:medications
1301:Categories
830:Odds ratio
822:Risk ratio
788:Prevalence
774:Occurrence
750:Case study
446:January 3,
421:January 3,
250:References
137:Following
30:See also:
1203:Bioethics
890:Morbidity
878:Virulence
780:Incidence
481:198003937
149:studies.
1054:Glossary
1047:Category
924:In vitro
765:Measures
584:Overview
398:26587202
213:See also
97:efficacy
93:toxicity
52:efficacy
1172:Biobank
1124:Justice
929:In vivo
530:9 March
508:28 June
389:4648212
355:9 March
318:9 March
289:9 March
201:In the
166:In the
60:devices
1112:Rights
1106:rights
479:
396:
386:
382:: 22.
205:, the
127:Phases
66:, and
868:Other
477:S2CID
86:) or
707:vs.
575:and
532:2024
510:2022
448:2024
423:2024
394:PMID
357:2024
320:2024
291:2024
469:doi
384:PMC
176:FDA
1303::
904:,
900:,
896:,
892:,
888:,
884:,
880:,
876:,
858:,
854:,
850:,
832:,
828:,
824:,
820:,
816:,
812:,
794:,
790:,
786:,
782:,
711:,
489:^
475:.
439:.
414:.
392:.
378:.
374:.
328:^
299:^
258:^
62:,
58:,
1096:e
1089:t
1082:v
741:)
737:(
698:)
694:(
645:)
641:(
565:e
558:t
551:v
534:.
512:.
483:.
471::
450:.
425:.
400:.
380:7
359:.
322:.
293:.
174:(
40:.
20:)
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.